Answers are grounded in this paper and cite their sources.
Background Individuals with HIV remain at higher risk of non-communicable diseases associated with interleukin-6-specific (IL-6) inflammation compared to the background population. Despite antiretroviral therapy, some individuals exhibit persistent hyperinflammation. We characterise these understudied longitudinal profiles and distinguish the predictors of chronic versus acute inflammation. Methods A subset from the Strategic Timing of Antiretroviral Treatment (START) trial with up to seven years of biomarker follow-up was included. Inflammatory states were defined based on plasma IL-6 levels, measured at randomisation, months eight, 12, and annually until 84. Hyperinflammation was defined as IL-6>1.8 pg/mL; ≥2 consecutive elevated measurements defined persistent hyperinflammation and a single elevated bracketed by non-elevated measurements defined IL-6 blips. Variables associated with these outcomes were analysed by generalized estimating equations. Results Among 2,102 individuals with a median of 5 (IQR: 4-6) measurements, 861 (41%) had persistent hyperinflammation whereas 575 (27%) had blips. Participants with BMI≥40 versus 18.5 to <25 (OR: 5.49, 95%CI: 4.18-7.20) and females with black ethnicity versus white males (2.58, 2.17-3.06) had increased risk of persistent hyperinflammation but not blips. Other persistent hyperinflammation predictors included higher white blood cell (WBC) counts, HIV-1 RNA, total cholesterol to high-density lipoprotein ratio >5, older age, smoking and diabetes. Of these only higher WBCs were also associated with blips. Conclusions Persistent hyperinflammation is strongly associated with demographic characteristics, comorbidities, and HIV-1 RNA, whereas blips were associated with markers of immune activation. Longitudinal IL-6 measurements are needed to distinguish persistent hyperinflammation from blips, which can lead to establishing a “high-risk phenotype” to target for clinical intervention.
No takes yet. Share an insight, caveat, or question.
Kjærgaard et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: